The aggregation and fibrillation of alpha-synuclein - PubMed (original) (raw)
Review
The aggregation and fibrillation of alpha-synuclein
Anthony L Fink. Acc Chem Res. 2006 Sep.
Abstract
alpha-Synuclein is a small (14 kDa), abundant, intrinsically disordered presynaptic protein, whose aggregation is believed to be a critical step in Parkinson's disease (PD). The kinetics of alpha-synuclein fibrillation are consistent with a nucleation-dependent mechanism, in which the critical early stage of the structural transformation involves a partially folded intermediate. Although the basis for the toxic effects of aggregated alpha-synuclein are unknown, it has been proposed that transient oligomers are responsible, possibly by forming pores in membranes. In this Account, I discuss our investigations into the molecular basis for alpha-synuclein aggregation/fibrillation, including factors that either accelerate or inhibit fibrillation, effects of molecular crowding, oxidation, point mutations, and lipid membranes, as well as the variety of conformational and oligomeric states that alpha-synuclein can adopt. It is apparent that neuronal cells must have a very fine balance of factors that control the levels and potential aggregation of alpha-synuclein.
Similar articles
- Effects of nitration on the structure and aggregation of alpha-synuclein.
Uversky VN, Yamin G, Munishkina LA, Karymov MA, Millett IS, Doniach S, Lyubchenko YL, Fink AL. Uversky VN, et al. Brain Res Mol Brain Res. 2005 Mar 24;134(1):84-102. doi: 10.1016/j.molbrainres.2004.11.014. Brain Res Mol Brain Res. 2005. PMID: 15790533 - Structural properties of pore-forming oligomers of alpha-synuclein.
Kim HY, Cho MK, Kumar A, Maier E, Siebenhaar C, Becker S, Fernandez CO, Lashuel HA, Benz R, Lange A, Zweckstetter M. Kim HY, et al. J Am Chem Soc. 2009 Dec 2;131(47):17482-9. doi: 10.1021/ja9077599. J Am Chem Soc. 2009. PMID: 19888725 - DNA induces folding in alpha-synuclein: understanding the mechanism using chaperone property of osmolytes.
Hegde ML, Rao KS. Hegde ML, et al. Arch Biochem Biophys. 2007 Aug 1;464(1):57-69. doi: 10.1016/j.abb.2007.03.042. Epub 2007 Apr 26. Arch Biochem Biophys. 2007. PMID: 17537399 - Controlling the mass action of alpha-synuclein in Parkinson's disease.
Kim C, Lee SJ. Kim C, et al. J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. J Neurochem. 2008. PMID: 18691382 Review. - Α-synuclein misfolding and Parkinson's disease.
Breydo L, Wu JW, Uversky VN. Breydo L, et al. Biochim Biophys Acta. 2012 Feb;1822(2):261-85. doi: 10.1016/j.bbadis.2011.10.002. Epub 2011 Oct 12. Biochim Biophys Acta. 2012. PMID: 22024360 Review.
Cited by
- Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism.
Jiang M, Porat-Shliom Y, Pei Z, Cheng Y, Xiang L, Sommers K, Li Q, Gillardon F, Hengerer B, Berlinicke C, Smith WW, Zack DJ, Poirier MA, Ross CA, Duan W. Jiang M, et al. J Neurochem. 2010 Jul;114(2):419-29. doi: 10.1111/j.1471-4159.2010.06752.x. Epub 2010 Apr 19. J Neurochem. 2010. PMID: 20412383 Free PMC article. - Effect of dioxygen on copper(II) binding to alpha-synuclein.
Lucas HR, Lee JC. Lucas HR, et al. J Inorg Biochem. 2010 Mar;104(3):245-9. doi: 10.1016/j.jinorgbio.2009.12.010. Epub 2009 Dec 23. J Inorg Biochem. 2010. PMID: 20064662 Free PMC article. - A sensitive probe for amyloid fibril detection with strong fluorescence and early response.
Zheng X, Xu Z, Li H, Fu H. Zheng X, et al. RSC Adv. 2018 Apr 27;8(29):15870-15875. doi: 10.1039/c8ra00751a. eCollection 2018 Apr 27. RSC Adv. 2018. PMID: 35542196 Free PMC article. - NLRP3 inflammasome in neurodegenerative disease.
Anderson FL, Biggs KE, Rankin BE, Havrda MC. Anderson FL, et al. Transl Res. 2023 Feb;252:21-33. doi: 10.1016/j.trsl.2022.08.006. Epub 2022 Aug 8. Transl Res. 2023. PMID: 35952982 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources